Skip to main content
. 2016 Jan 28;90(4):1705–1717. doi: 10.1128/JVI.02417-15

TABLE 3.

Fold changes in antiviral pathway mRNA transcript counts upon RSV-A2 infection and treatment with antiviral compounds in A549 cellsa

Product category and gene Fold change in antiviral pathway mRNA transcript counts
DMSO TMC-353121 RSV-604 YM-53403 BI-D
Pattern recognition receptors
    DDX58 (RIG-I) 37 51 33 23 166
    IFIH1 (MDA-5) 155 191 120 87 724
    DHX58 (LGP2) 101 82 45 63 349
    TLR3 12 30 20 11 48
    TLR4 1 −2 −2 3 5
    TLR7 1 2 1 −1 2
    TLR9 2 2 2 1 1
Mitochondrial signaling
    MAVS −1 −1 1 −1 −1
    TMEM173 (Sting) 10 8 2 6 17
    TRAP −2 −1 −2 −1 −2
    TBK1 −1 1 −1 −1 1
    IKBKG (Nemo) −1 1 1 1 1
Transcription factors
    IRF1 11 10 6 6 21
    IRF3 −1 1 −1 1 1
    IRF7 27 62 57 27 60
    IRF9 24 33 32 23 53
    NFKB1 2 2 2 2 3
    NFKB2 5 4 4 3 7
Type I, II, and III interferons
    IFN-α1 1 1 1 1 31
    IFN-α10 1 1 1 1 10
    IFN-α13 6 1 1 1 42
    IFN-α7 1 1 1 1 16
    IFN-β1 130 42 25 18 1,753
    IL-6 508 159 66 55 954
    IFN-γ 1 1 1 1 13
    IL28A 383 239 48 74 2,161
    IL28B 202 119 23 43 954
    IL-29 1,778 647 265 259 6,013
ISGs
    CCL5 (RANTES) 147 67 51 87 1,168
    CX3CL1 (Fractalkine) 16 18 11 5 54
    CXCL10 (IP-10) 253 196 62 97 3,069
    CXCL11 321 187 86 145 2,357
    IFI27 443 855 671 551 1,349
    IFI44 1,695 2,703 1,469 1,127 4,487
    IFIT2 387 355 232 217 3,005
    IFIT3 159 220 118 116 761
    IFITM1 345 862 258 418 1,312
    ISG15 142 310 277 193 445
    ISG20 19 19 17 10 54
    OAS1 9 19 12 9 33
    OAS2 1,041 2,282 1,075 988 3,183
    OAS3 8 15 9 8 19
    OASL 754 713 602 562 4,339
    MX1 257 650 302 234 861
    MX2 102 337 130 84 415
    RSAD2 (Viperin) 228 211 140 57 2,170
    TSLP 4 1 1 1 16
a

Data are from the results of one RNA sequencing experiment. Selected genes were validated by RT-qPCR (Table 2) and protein expression as described in Results. ISGs, interferon-stimulated genes.